Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update
- PMID: 37269847
- DOI: 10.1016/S1470-2045(23)00216-4
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update
Conflict of interest statement
SDK declares honoraria from GSK outside the submitted work. NPvE declares grant payments made to the institution, from IDS Ipsen and IDS Astellas, and payments made to the institution for lectures, from Wad ‘n Workshop. All other authors declare no competing interests.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources